Dashboard
Manage Tickers

PFE PFIZER INC

NYSE pfizer.com


$ 24.41 nm (nm)    

Wednesday, 15-Oct-2025 17:11:17 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 602.32 nm (nm)
DIA $ 462.40 $ 0.00 (0 %)
SPY $ 665.03 nm (nm)
TLT $ 90.78 nm (nm)
GLD $ 387.22 $ 6.60 (1.73 %)
$ 24.52
$ 24.48
$ 24.40 x 337
$ 24.42 x 393
$ 24.21 - $ 24.58
$ 20.18 - $ 27.86
47,570,337
na
139.41B
$ 0.51
$ 12.97
TBD
na
na ($ 0.07)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-29-2025 10-Q
2 05-05-2025 03-30-2025 10-Q
3 02-27-2025 12-31-2024 10-K
4 11-04-2024 09-29-2024 10-Q
5 08-05-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 02-22-2024 12-31-2023 10-K
8 11-08-2023 10-01-2023 10-Q
9 08-09-2023 07-02-2023 10-Q
10 05-10-2023 04-02-2023 10-Q
11 02-23-2023 12-31-2022 10-K
12 11-09-2022 10-02-2022 10-Q
13 08-10-2022 07-03-2022 10-Q
14 05-11-2022 04-03-2022 10-Q
15 02-24-2022 12-31-2021 10-K
16 11-12-2021 10-03-2021 10-Q
17 08-12-2021 07-04-2021 10-Q
18 05-13-2021 04-04-2021 10-Q
19 02-25-2021 12-31-2020 10-K
20 11-05-2020 09-27-2020 10-Q
21 08-06-2020 06-28-2020 10-Q
22 05-07-2020 03-29-2020 10-Q
23 02-27-2020 12-31-2019 10-K
24 11-07-2019 09-29-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 02-28-2019 12-31-2018 10-K
28 11-08-2018 09-30-2018 10-Q
29 08-09-2018 07-01-2018 10-Q
30 05-10-2018 04-01-2018 10-Q
31 02-22-2018 12-31-2017 10-K
32 11-09-2017 10-01-2017 10-Q
33 08-10-2017 07-02-2017 10-Q
34 05-11-2017 04-02-2017 10-Q
35 02-23-2017 12-31-2016 10-K
36 11-10-2016 10-02-2016 10-Q
37 08-11-2016 07-03-2016 10-Q
38 05-12-2016 04-03-2016 10-Q
39 02-29-2016 12-31-2015 10-K
40 11-05-2015 09-27-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

reported-earlier-pfizer-ceo-says-us-pharma-industry-needs-to-collaborate-with-china--reuters
Reported Earlier: 'Pfizer CEO says US phar...
10/15/2025 11:43:40

https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-ceo-says-us-pharma-industry-needs-collaborate-with-china-202...

wall-streets-most-accurate-analysts-spotlight-on-3-health-care-stocks-with-over-3-dividend-yields
Wall Street's Most Accurate Analysts Spotl...
10/15/2025 11:15:13

pfizer-seeks-expanded-use-approval-for-breast-cancer-drug
Pfizer Seeks Expanded Use Approval For Bre...
10/14/2025 17:37:12

Pfizer's Tukysa improved progression-free survival in first-line HER2+ metastatic breast cancer, showing strong efficacy an...

hedge-fund-shah-capital-urges-novavax-to-consider-sale-amid-vaccine-rollout-struggles-sees-5-billion-potential
Hedge Fund Shah Capital Urges Novavax To C...
10/14/2025 17:08:17

Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at least...

pfizer-announces-topline-results-from-phase-3-her2climb-05-trial-of-first-line-combination-therapy-with-tyrosine-kinase-inhibitor-tukysa-in-patients-with-her2-mbc
Pfizer Announces Topline Results From Phas...
10/14/2025 10:46:49

Pfizer Inc. (NYSE:PFE) today announced positive topline results from the Phase 3 HER2CLIMB-05 trial of first-line combination t...

Core News & Articles
Arvinas And Pfizer To Highlight New Vepdeg...
10/13/2025 11:08:29

Presentation to include new patient-reported outcomes (PRO) data from the Phase 3 VERITAC-2 clinical trial 

pfizer-to-present-46-infectious-disease-abstracts-at-idweek-2025-congress-highlighting-advancements-in-prevention-and-treatment
Pfizer To Present 46 Infectious Disease Ab...
10/13/2025 10:47:25

Pfizer Inc. (NYSE:PFE, "Pfizer"))) will present data across its infectious disease portfolio at the upcoming IDWeek 202...

Core News & Articles
President Trump Announces Achievement On D...
10/10/2025 21:37:40

https://www.youtube.com/watch?v=XOtOCzut9pM

trump-plans-astrazeneca-deal-to-cut-drug-prices-for-low-income-americans
Trump Plans AstraZeneca Deal To Cut Drug P...
10/10/2025 18:48:27

Trump to announce new deal with AstraZeneca to lower prescription drug costs for Americans using most-favored-nation pricing mo...

morgan-stanley-maintains-equal-weight-on-pfizer-lowers-price-target-to-32
Morgan Stanley Maintains Equal-Weight on P...
10/10/2025 17:42:29

Morgan Stanley analyst Terence Flynn maintains Pfizer (NYSE:PFE) with a Equal-Weight and lowers the price target from $33 to...

trump-administration-engages-pharmacies-goodrx-for-trumprx-launch
Trump Administration Engages Pharmacies, G...
10/09/2025 19:09:34

Pharmacies and GoodRx are in talks to join TrumpRx, a new drug pricing site aiming to lower prescription costs for U.S. consumers.

Core News & Articles
10 Health Care Stocks Whale Activity In To...
10/08/2025 17:35:32

amgen-to-offer-cholesterol-drug-at-60-discount-as-trump-administrations-call-to-lower-drug-prices
Amgen To Offer Cholesterol Drug At 60% Dis...
10/06/2025 18:27:22

Amgen launches AmgenNow, offering Repatha at $239 per month, expanding direct access for U.S. patients with no insurer restrict...

Core News & Articles
10 Health Care Stocks Whale Activity In To...
10/06/2025 17:35:26

wall-street-hits-record-highs-as-rate-cut-bets-offset-shutdown-this-week-in-markets
Wall Street Hits Record Highs As Rate Cut ...
10/03/2025 20:15:46

S&P500, Nasdaq100, Dow Jones, and Russell 2000 all hit record highs as investors focus on corporate optimism, monetary easi...

demystifying-pfizer-insights-from-4-analyst-reviews
Demystifying Pfizer: Insights From 4 Analy...
10/03/2025 19:01:53

b-of-a-securities-maintains-neutral-on-pfizer-raises-price-target-to-30
B of A Securities Maintains Neutral on Pfi...
10/03/2025 13:08:51

B of A Securities analyst Tim Anderson maintains Pfizer (NYSE:PFE) with a Neutral and raises the price target from $28 to $30.

these-3-pharma-stocks-are-rallying--and-still-trade-absurdly-cheap
These 3 Pharma Stocks Are Rallying – And S...
10/02/2025 19:43:25

Health care stocks are rallying, but Pfizer, Merck and Bristol-Myers still trade below 10x forward P/E — a rare market discount.

a-look-into-pfizer-incs-price-over-earnings
A Look Into Pfizer Inc's Price Over Earnings
10/02/2025 16:00:49

trump-pfizer-deal-pushes-health-care-stocks-to-best-rally-in-5-years
Trump-Pfizer Deal Pushes Health Care Stock...
10/01/2025 20:22:35

Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tari...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION